You are here
Home 🌿 Medical Cannabis News 🌿 Medical Marijuana Leads To Less Hospitalizations For IBS Patients 🌿Medical Marijuana Leads To Less Hospitalizations For IBS Patients

New data shows IBS patients who used marijuana experienced less hospitalizations and shorter visits compared to non-users.
Irritable Bowel Syndrome (IBS) is a frustrating and isolating illness for many patients. One study estimates that up to 20% of Americans experience IBS, which is considered a chronic disease. Some patients have manageable symptoms and are able to proceed uninterrupted throughout their day. For others, the gastrointestinal disorder can lead to a poor quality of life. Research indicates those with IBS miss three times as many workdays as those without bowel symptoms.
Now, researchers at Rutgers University suggest in a new study that marijuana can help ease the suffering of patients with severe IBS symptoms. The study was presented online this week in an event organized by Digestive Disease Week — a conference to begin May 2 in Chicago but canceled due to coronavirus concerns.
Researchers analyzed 2016 data of Nationwide Readmissions Database from the Agency for Healthcare Research and Quality, comparing IBS patients who were cannabis users vs. non-cannabis users. Among non-cannabis users, all-cause 30-day readmission rates were 12.7%. In cannabis users, that figures was only 8.1%. The study also found cannabis use correlated with shorter hospital stays and overall lower hospitalization charges.
Photo by Bill Oxford/Getty Images
The study included 6,798 adult IBS patients, 357 of which were identified as cannabis users. The non-cannabis group had a mean age of about 53 years while marijuana users were about 36 years on average. Women were the primary gender in both cannabis users (62%) and non-users (81%)—which is expected, as IBS affects more women than men.
There is no cure for IBS, but a 2005 report indicated that marijuana could provide future therapeutic potential for patients. Unfortunately, there aren’t many studies around how marijuana treats IBS. A 2015 medical survey found that 70% of IBS patients who used CBD experienced improved moods as a result. Before using CBD, participants reported an average pain score of seven. Following CBD use, the pain score dropped to four.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.